Ipilimumab

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
hm, interesting. I did not know CTLA-4 inhibitors were this close to becoming used in clinical settings. I could definitely see this drug causing problems with overreactive t cells, especially in patients who may be susceptible to auto immune disease.
 
They all **** their brains out....
 
Top Bottom